WST

West Pharmaceutical Services, Inc.

Healthcare
316.31 +4.14 +1.33% Market Closed
2026-06-03 • USD

Key Metrics

Market Cap 22.35B
EV —
Shares Out 70.65M
Revenue (ttm) 3.22B
Net Income 542.70M
Beta —
P/E 41.99
Forward P/E —
EPS (ttm) $7.48
P/S —
P/B 7.62
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 13.21%
ROE 18.34%
ROIC —
Gross Margin 36.28%
Oper. Margin 20.34%
Profit Margin 16.85%
Debt/Eq 0.11
LT Debt/Eq 6.35%
Quick Ratio —
Current Ratio 2.71
Book/sh 41.53
Cash/sh 7.24
Div Yield 0.28%
Div TTM $0.87
Payout Ratio 11.63%
SMA20 0.98%
SMA50 9.61%
SMA200 18.38%
Volume 636,100
Avg Volume 929.40K
Rel Volume —
Perf Week -2.01%
Perf Month 2.05%
Perf Quarter 29.45%
Perf Half Y 12.88%
Perf YTD 14.96%
Perf Year 44.71%
Perf 3Y -7.89%
Perf 5Y -5.13%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.2200
TTM Yield 0.28%
TTM Amount $0.87
Payout Ratio 11.63%
3-Yr Growth (CAGR) 5.14%
5-Yr Growth (CAGR) 5.44%

Last 12 Payouts

Period Ex-Date Amount / Share
Q1 2026 ~2026-03-31 $0.2200
Q4 2025 ~2025-12-30 $0.2200
Q3 2025 ~2025-09-30 $0.2200
Q2 2025 ~2025-06-30 $0.2100
Q1 2025 ~2025-03-31 $0.2100
Q2 2024 ~2024-06-30 $0.2000
Q1 2024 ~2024-03-31 $0.2000
Q2 2023 ~2023-06-30 $0.1900
Q1 2023 ~2023-03-31 $0.1900
Q2 2022 ~2022-06-30 $0.1800
Q1 2022 ~2022-03-31 $0.1800
Q2 2021 ~2021-06-30 $0.1700

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

West Pharmaceutical Services, Inc. is a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two business segments: (1) Proprietary Products, which offers elastomers & primary containment, drug delivery devices, integrated systems, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers, including stoppers and seals for injectable packaging systems, syringe and cartridge components, vials, syringes, plungers, cartridges, and self-injection devices, as well as films, coatings, washing, vision inspection and sterilization processes; and (2) Contract-Manufactured Products, which provides fully integrated design, manufacture, and automated assembly of complex devices for pharmaceutical, diagnostic, and medical device customers, including custom contract-manufacturing and assembly solutions using multi-component molding, in-mold labeling, ultrasonic welding, and clean room molding. The Company's customers include leading biologic, generic, pharmaceutical, diagnostic, and medical device companies worldwide. West manufactures approximately 41 billion components and devices annually across 25 global manufacturing sites with over 10,000 employees, delivering thousands of injectable therapies to millions of patients daily.

Name
West Pharmaceutical Services, Inc.
Industry
Medical Devices
CEO
Eric M. Green · President, Chief Executive Officer and Chair of the Board
Employees
10,000 as of 2025-12-31
IPO Date
2014-06-24
Phone
(610) 594-2900
Address
530 Herman O. West Drive, Exton, PA 19341-1147
Website
www.westpharma.com

Key Executives

Name Title FY Pay
Deborah L. V. Keller Board Member —
Molly E. Joseph Board Member —
Janet B. Haugen Board Member —
Mark A. Buthman Board Member —
Eric M. Green President, Chief Executive Officer and Chair of the Board —

Latest News